Get started
Author

Sylvia G. Stankov

Observed names: Stankov, Sylvia, Stankov, Sylvia G, Sylvia Stankov
ORCID: 0000-0002-6775-7564
Observed ORCID: 0000-0002-6775-7564
OpenAlex ID: A5063954041
Gene editing for dyslipidemias: New tools to “cut” lipids
2023 · Sylvia Stankov, Marina Cuchel · Atherosclerosis · 32
PDF
Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following Gene Therapy
2019 · Angela L. McCall, Sylvia G. Stankov, et al. · Current Gene Therapy · 20
ILRUN Promotes Atherosclerosis Through Lipid-Dependent and Lipid-Independent Factors
2022 · Xin Bi, Sylvia Stankov, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 7
Gain-of-Function Variants in Lipid Genes Enhance Biological Insight and Point Toward Therapeutic Opportunities
2022 · Sylvia Stankov, Cecilia Vitali, et al. · Circulation · 3
PDF
Comparison of the structure-function properties of wild-type human apoA-V and a C-terminal truncation associated with elevated plasma triglycerides
2023 · Sylvia Stankov, Cecilia Vitali, et al. · medRxiv · 1
PDF
Abstract 121: Exploiting Natural Genetic Variation In The Human Triglyceride Regulator APOA5 To Understand Its Function
2021 · Sylvia Stankov, Cecilia Vitali, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1
ApoC-III helical structure determines its ability to bind plasma lipoproteins and inhibit Lipoprotein Lipase-mediated triglyceride lipolysis
2020 · Cecilia Vitali, Sylvia Stankov, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Leveraging Natural Genetic Variation in the Human Triglyceride Regulator Apoa5 to Understand Its Function
2023 · Stankov, Sylvia · ScholarlyCommons (University of Pennsylvania)
382. Correction of Autophagic Dysregulation in Pompe Disease Following Gene Therapy
2016 · Angela L. McCall, Sylvia G. Stankov, et al. · Molecular Therapy
PDF
Works count: 10
Citation count: 65
H-index: 3
I10-index: 2
Year
Topic
Type